Kang Yuan Pharmaceutical (600557.SH) part of the board of directors plans to collectively increase their holdings by no less than 120,000 shares of the company's stock.

China Fortune Financial News APP News, Kangyuan Pharmaceutical (600557.SH) announced that Mr. Yang Yongchun, the director and general manager of the company, Mr. Gao Haixin, director, Mr. Chen Xuebin, director, Mr. Liu Quan, deputy general manager, Mr. Wang Chuanlei, deputy general manager, and Mr. Pan Yu, deputy general manager, based on their confidence in the future development of the company and their recognition of the long-term investment value of the company, plan to increase their holdings of the company's shares by a total of not less than 120,000 shares within one month from the date of the announcement through the Shanghai Stock Exchange trading system in a centralized competitive manner using their own funds.